Skip to search formSkip to main contentSkip to account menu

vanoxerine

Known as: 1-(2 (bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, 1-(2-(bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, vanoxeamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy. Although a potent… 
Review
2012
Review
2012
Cocaine abuse is a serious health problem in many areas of the world, yet there are no proven effective medications for the… 
2010
2010
Cellular Electrophysiology of Vanoxerine. Introduction: There remains an unmet need for safe and effective antiarrhythmic drugs… 
Review
2007
Review
2007
  • A. Preti
  • Addiction biology
  • 2007
  • Corpus ID: 21834607
Despite huge advances in the neuroscience of substance abuse and dependence in the past 20 years, no approved pharmacological… 
Review
2000
Review
2000
  • A. Preti
  • Current opinion in investigational drugs
  • 2000
  • Corpus ID: 42738156
Vanoxerine (GBR-12909) is a high-affinity dopamine reuptake inhibitor that was synthesized in the late 1970s and was initially…